Lixte Biotechnology Pivots to Energy Storage Amid Stock Slide

This strategic shift began June 1, when Lixte announced its intent to transform into an AI-driven energy infrastructure business. While the company is currently seeking a partner to offload its existing medical technology and drug development assets, investors reacted skeptically to the transition. The stock remains up 63% for the year despite the recent sell-off.

Lixte has not disclosed the financial terms of the Nomad acquisition. The target company, which specializes in mobile utility-grade battery storage, reported a 175% revenue increase in 2025. Lixte emphasizes that Nomad’s mobile systems provide a logistical advantage over traditional, permanent battery energy storage projects, which often face development delays spanning two to five years.